Therefore, the main aim of the present study is to evaluate the diagnostic sensitivity of the SCF plasma level for GBM and the correlation of this biomarker with the GBM patients’ tumor volume, prognosis, and overall survival to evaluate its significance as an independent blood‐circulating diagnostic and prognostic biomarker. Here, KITLG is linked to glioblastoma.